Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum

Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum

Celiac Disease (CD) is an interferon (IFN)γ-mediated duodenal hypersensitivity to wheat gluten occurring in genetically predisposed individuals. Gluten-free diet (GFD) leads to a complete remission of the disease. Vα24-restricted invariant NKT (iNKT) cells are important to maintain immune homeostasi...

Full description

Bibliographic Details
Main Authors:	Enrique Montalvillo, David Bernardo, Beatriz Martínez-Abad, Yessica Allegretti, Luis Fernández-Salazar, Carmen Calvo, Fernando G. Chirdo, José A. Garrote, Eduardo Arranz
Format:	Article
Language:	English
Published:	MDPI AG 2015-10-01
Series:	Nutrients
Subjects:	Celiac Disease Intraepithelial Lymphocytes iNKT Vα24-Jα18 IFNγ Celiac Disease-like molecular profile
Online Access:	http://www.mdpi.com/2072-6643/7/11/5444

Similar Items

Cell Density Counts of the Intestinal Intraepithelial Lymphocytes in the Celiac Patients
by: Hadi Hossein-Nataj, et al.
Published: (2019-06-01)

Innate Lymphoid Cells and Celiac Disease: Current PerspectiveSummary
by: Xuechen Yu, et al.
Published: (2021-01-01)

The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead
by: Adam Nelson, et al.
Published: (2021-10-01)

Evaluation and Specification of Intraepithelial Lymphocyte Cut-off Point with Hematoxiline-Eosine (H&E) and Immunohistochemistry (CD3 Marker) in Duodenal Biopsy of Children with Celiac Disease
by: Mojgan Mokhtari, et al.
Published: (2018-04-01)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
by: Benjamin J. Wolf, et al.
Published: (2018-03-01)

Editorial: NKT Cells in Cancer Immunotherapy
by: Tonya J. Webb, et al.
Published: (2020-06-01)

NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases—Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome
by: Michał K. Zarobkiewicz, et al.
Published: (2021-09-01)

Erratum: Editorial: NKT Cells in Cancer Immunotherapy
by: Frontiers Production Office
Published: (2020-08-01)

Mucosal molecular pattern of tissue transglutaminase and interferon gamma in suspected seronegative celiac disease at marsh 1 and 0 stages
by: Enzo Ierardi, et al.
Published: (2015-01-01)

Description of invariant NKT cells.
by: Katarzyna Karwicka, et al.
Published: (2021-09-01)

More fuel to the fire: some patients with non-celiac self-reported wheat sensitivity exhibit adaptive immunological responses in duodenal mucosa
by: Antonia Isabel Castillo-Rodal, et al.
Published: (2020-12-01)

Generalized edema as the dominant clinical symptom of celiac crisis
by: Dominika Wilczyńska, et al.
Published: (2021-12-01)

α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
by: Yingting Zhang, et al.
Published: (2019-06-01)

Magnifying endoscopy of the duodenum with dye scattering method in a case with celiac disease
by: Tetsuo Morishita, et al.
Published: (2003-06-01)

Progression of pediatric celiac disease from potential celiac disease to celiac disease: a retrospective cohort study
by: Shruti Sakhuja, et al.
Published: (2021-03-01)

iNKT Cells and Their potential Lipid Ligands during Viral Infection
by: Anunya eOpasawatchai, et al.
Published: (2015-07-01)

CCR7 defines a precursor for murine iNKT cells in thymus and periphery
by: Haiguang Wang, et al.
Published: (2018-08-01)

Invariant natural killer T cells minimally influence gut microbiota composition in mice
by: Qiaochu Lin, et al.
Published: (2022-12-01)

Invariant Natural Killer T (iNKT) Cells Prevent Autoimmunity, but Induce Pulmonary Inflammation in Cystic Fibrosis
by: Nanna Siegmann, et al.
Published: (2014-06-01)

Akt2 Regulates the Differentiation and Function of NKT17 Cells via FoxO-1-ICOS Axis
by: LinLin Niu, et al.
Published: (2018-09-01)

Management of celiac disease: from evidence to clinical practice
by: Tiziana M. Attardo, et al.
Published: (2017-11-01)

Activation mechanisms of invariant natural killer T cells (iNKTs)
by: Baena, Andrés, et al.
Published: (2016-01-01)

Corrigendum: Akt2 Regulates the Differentiation and Function of NKT17 Cells via FoxO-1-ICOS Axis
by: LinLin Niu, et al.
Published: (2020-09-01)

Should we look for Celiac Disease in Irritable Bowel Syndrome?
by: Sima Besharat
Published: (2011-01-01)

Electrochemical DNA Biosensor That Detects Early Celiac Disease Autoantibodies
by: Anna B. N. Nguyen, et al.
Published: (2021-04-01)

Melanoma Cells Inhibit iNKT Cell Functions via PGE2 and IDO1
by: Enza Torre, et al.
Published: (2023-07-01)

CD8+ T-cell immunity orchestrated by iNKT cells
by: Yingyu Qin, et al.
Published: (2023-01-01)

The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation
by: Yajun Wang, et al.
Published: (2017-07-01)

Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients
by: Diana Ferraro, et al.
Published: (2021-11-01)

Reduction of Peripheral Blood iNKT and γδT Cells in Patients With Parkinson's Disease: An Observational Study
by: Chao Zhou, et al.
Published: (2020-06-01)

Celiac disease
by: Dina I Shehab
Published: (2013-01-01)

RE: Celiac Disease Prevalence in Omani Children with Type 1 Diabetes Mellitus
by: Siham Al Sinani
Published: (2013-11-01)

Celiac Crisis in an Adult: Raising Awareness to a Life-Threatening Condition
by: Rogerio Vicente Ferreira, et al.
Published: (2016-02-01)

Tumor epitope spreading by a novel multivalent therapeutic cellular vaccine targeting cancer antigens to invariant NKT-triggered dendritic cells in situ
by: Satoru Yamasaki, et al.
Published: (2024-02-01)

Old and New Adjunctive Therapies in Celiac Disease and Refractory Celiac Disease: A Review
by: Marco Valvano, et al.
Published: (2023-08-01)

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
by: Lisa A. King, et al.
Published: (2018-07-01)

Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
by: Lisa A. King, et al.
Published: (2018-11-01)

CD1d-Dependent iNKT Cells Control DSS-Induced Colitis in a Mouse Model of IFNγ-Mediated Hyperinflammation by Increasing IL22-Secreting ILC3 Cells
by: Hyun Jung Park, et al.
Published: (2021-01-01)

Activation of iNKT Cells Facilitates Liver Repair After Hepatic Ischemia Reperfusion Injury Through Acceleration of Macrophage Polarization
by: Takuya Goto, et al.
Published: (2021-10-01)

License to Kill: When iNKT Cells Are Granted the Use of Lethal Cytotoxicity
by: Angélica Díaz-Basabe, et al.
Published: (2020-05-01)